Gene · 10
Papers3,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer. | Front Immunol | 2022 | 36479114 | PubTator, text mining | PubMed |
| Filling the gaps in the research about second primary malignancies after bladder cancer: Focus on race and histology. | Front Public Health | 2022 | 36466542 | PubTator, text mining | PubMed |
| An update of the consensus statement on insulin resistance in children 2010. | Front Endocrinol (Lausanne) | 2022 | 36465645 | PubTator, text mining | PubMed |
| Exploring potential shared genetic influences between rheumatoid arthritis and blood lipid levels. | Atherosclerosis | 2022 | 36455308 | PubTator, text mining | PubMed |
| Joint Analysis of Phenotypic and Genomic Diversity Sheds Light on the Evolution of Xenobiotic Metabolism in Humans. | Genome Biol Evol | 2022 | 36445690 | PubTator, text mining | PubMed |
| Editorial: Pharmacogenomics in neglected populations. | Front Pharmacol | 2022 | 36438814 | PubTator, text mining | PubMed |
| Relevance of CYP2D6 Gene Variants in Population Genetic Differentiation. | Pharmaceutics | 2022 | 36432672 | PubTator, text mining | PubMed |
| Ficolin-2: A potential immune-related therapeutic target with low expression in liver cancer. | Front Oncol | 2022 | 36425563 | PubTator, text mining | PubMed |
| Complementary medicines used in ulcerative colitis and unintended interactions with cytochrome P450-dependent drug-metabolizing enzymes. | Turk J Med Sci | 2022 | 36422483 | PubTator, text mining | PubMed |
| Rates of Divergent Pharmacogenes in a Psychiatric Cohort of Inpatients with Depression-Arguments for Preemptive Testing. | J Xenobiot | 2022 | 36412766 | PubTator, text mining | PubMed |
| Pharmacogenes that demonstrate high association evidence according to CPIC, DPWG, and PharmGKB. | Front Med (Lausanne) | 2022 | 36388934 | PubTator, text mining | PubMed |
| Acetyl coenzyme A kinetic studies on N-acetylation of environmental carcinogens by human N-acetyltransferase 1 and its NAT1*14B variant. | Front Pharmacol | 2022 | 36386142 | PubTator, text mining | PubMed |
| Amifampridine for Lambert-Eaton myasthenic syndrome. | Aust Prescr | 2022 | 36382167 | PubTator, text mining | PubMed |
| Identification of Potential Prognostic Markers and Key Therapeutic Targets in Hepatocellular Carcinoma Using Weighted Gene Co-Expression Network Analysis: A Systems Biology Approach. | Iran J Biotechnol | 2022 | 36381283 | PubTator, text mining | PubMed |
| Pharmacogenetic variability and the probability of site of action target attainment during tuberculosis meningitis treatment: A physiologically based pharmacokinetic modeling and simulations study. | Tuberculosis (Edinb) | 2022 | 36375279 | PubTator, text mining | PubMed |
| Design, Synthesis, and Bioassay of 2'-Modified Kanamycin A. | Molecules | 2022 | 36364310 | PubTator, text mining | PubMed |
| Development of necroptosis-related gene signature to predict the prognosis of colon adenocarcinoma. | Front Genet | 2022 | 36353119 | PubTator, text mining | PubMed |
| Interaction between blood pressure and genetic risk score for bladder cancer, and risk of urothelial carcinoma in men. | Sci Rep | 2022 | 36316463 | PubTator, text mining | PubMed |
| Evidence for Implementation: Management of TB in HIV and Pregnancy. | Curr HIV/AIDS Rep | 2022 | 36308580 | PubTator, text mining | PubMed |
| Reprogramming Carbohydrate Metabolism in Cancer and Its Role in Regulating the Tumor Microenvironment. | Subcell Biochem | 2022 | 36301490 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10/papers?page=18